Under COMPETE P2030, AccelBio has secured approval for Bio-Transfer: Biomedical Knowledge Commercialization Program, a joint initiative led by i3S, AccelBio, and CoLAB Trials. 

Bio-Transfer aims to strengthen biomedical technology transfer and commercialisation through an integrated national framework and five interconnected actions, including: 

• A progress-tracking directory for innovation ready to transition to bioindustry (Bioinnovation Golden Basket) 

• A learning and sharing cycle of talks (BioInnovators Podcast) 

• A CRM system connecting target companies and expert connectors (Licensing Operating System) 

• Maturation and industry-readiness activities (Bioinnovation Step-Ups) 

• A partnership-promotion tour linking startups and industry (Bio Meetings Route) 

The programme will also track the progress of supported startups and consolidate learnings into a community-facing white paper.